Humana Inc. $HUM Shares Purchased by Continuum Advisory LLC

Continuum Advisory LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 12.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,405 shares of the insurance provider’s stock after purchasing an additional 2,032 shares during the period. Continuum Advisory LLC’s holdings in Humana were worth $4,788,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Revolve Wealth Partners LLC purchased a new stake in shares of Humana during the 4th quarter valued at approximately $202,000. State of Wyoming increased its stake in Humana by 10.1% during the first quarter. State of Wyoming now owns 850 shares of the insurance provider’s stock worth $225,000 after acquiring an additional 78 shares during the last quarter. Vident Advisory LLC raised its position in Humana by 42.2% in the first quarter. Vident Advisory LLC now owns 2,456 shares of the insurance provider’s stock valued at $650,000 after purchasing an additional 729 shares during the period. Quarry LP acquired a new position in shares of Humana in the 1st quarter valued at $205,000. Finally, Retirement Planning Co of New England Inc. grew its holdings in shares of Humana by 7.7% during the 1st quarter. Retirement Planning Co of New England Inc. now owns 1,040 shares of the insurance provider’s stock worth $275,000 after purchasing an additional 74 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of HUM stock opened at $258.50 on Tuesday. The stock’s 50-day moving average is $258.07 and its two-hundred day moving average is $260.74. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The firm has a market cap of $31.09 billion, a price-to-earnings ratio of 24.23, a PEG ratio of 1.51 and a beta of 0.46.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. The firm had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The business’s revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the firm earned $4.16 EPS. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s payout ratio is presently 33.18%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Evercore ISI began coverage on shares of Humana in a research report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 target price on the stock. KeyCorp restated a “sector weight” rating on shares of Humana in a report on Friday, December 12th. Bank of America lifted their target price on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Sanford C. Bernstein upped their price target on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Finally, Truist Financial dropped their price objective on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research note on Monday, November 10th. Nine investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $294.32.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.